Clinical Trials Logo
  1. Home
  2. Plaque-type Psoriasis
  3. NCT00852761

A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type Psoriasis

Plaque-Type Psoriasis Clinical Trial

Official title:
A Study to Evaluate Safety and Efficacy of Clobetasol Propionate for Treatment of Plaque-Type Psoriasis in Adult Subjects.

Clinical Trial Summary

The purpose of the study is to determine the efficacy and safety of two different forms of a topical steroid (clobetasol propionate) in patients with plaque-type psoriasis.

Clinical Trial Description

This study is being conducted to obtain efficacy and tolerability data for two clobetasol propionate therapies in the treatment of plaque-type psoriasis. Subjects will be randomized to only one of the two therapies for treatment throughout the study. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00852761
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 4
Start date March 2009
Completion date August 2009
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT01936688 - A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012) Phase 3
Completed NCT00763503 - Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis Phase 2
Completed NCT00773734 - Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study) Phase 2
Completed NCT01636687 - Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) Phase 3
Completed NCT01258088 - Safety Study of Ointment for the Treatment of Plaque-type Psoriasis Phase 1
Completed NCT01132612 - AIN457 Regimen Finding Extension Study in Participants With Moderate to Severe Psoriasis Phase 2
Completed NCT00625326 - Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis Phase 2
Completed NCT01412944 - Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis Phase 3
Completed NCT00521339 - Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis Phase 2
Completed NCT01876875 - n-3 Polysaturated Fatty Acids-rich Diet in Psoriasis Phase 4